About Michael Cocchi
Dr. Cocchi currently practices as an attending physician in the emergency department and as an intensivist in the surgical intensive care units at BIDMC. After graduating from the University of Massachusetts Medical School, he completed his residency in Emergency Medicine at the Harvard Affiliated Emergency Medicine Residency at BIDMC, followed by a two-year fellowship in Critical Care Medicine. He is board certified in Emergency Medicine, Critical Care Medicine, and Neurocritical Care. His research interests have primarily focused on critical care topics, in particular cardiac arrest, sepsis, and shock. He is currently the Principal Investigator of a Phase II clinical trial studying the effects of esmolol in septic shock, funded by the American Heart Association. He is the course co-director of the biannual Harvard Shock Symposium, and has served as an evidence reviewer for the post cardiac arrest guidelines for the American Heart Association. In addition to his clinical duties and research, Dr. Cocchi’s administrative responsibilities include serving as the Director of Critical Care Quality for the Silverman Institute for Health Care Quality and Safety within the Department of Health Care Quality at BIDMC. In that role, he oversees all quality assurance-related matters, as well as quality improvement endeavors, across the 9 adult ICUs at BIDMC. He also serves as an Associate Medical Director for Boston MedFlight, an air and ground critical care transport service supporting the major teaching hospitals in Boston. A unifying theme of his clinical, research, and administrative work is improving the delivery of safe and high quality care to critically ill patients in the pre-hospital, ED and the ICU settings, in order to achieve improved outcomes for these most vulnerable patients.
Topics for Talks by Michael Cocchi
- Updates in post arrest care
- Proning in ARDS
- Management status epilepticus
About Maureen Chase
Dr. Maureen Chase began her research career at the Hospital of the University of Pennsylvania with a clinical research fellowship in the risk stratification of Emergency Department patients with chest pain. After joining the faculty at BIDMC, she continued her work in the early identification of patients with critical illnesses while working towards her Master in Public Health degree at the Harvard School of Public Health, publishing her work in the identification of patients with sepsis and bacteremia. She was awarded a Harvard Catalyst Pilot grant for her prospective investigation into patients with dizziness at risk for stroke that involved collaboration between the Emergency Departments at the three Harvard teaching hospitals. Via her MPH training and work within the Center for Resuscitation Science, Dr. Chase’s research focus transitioned toward early interventions for patients with critical illness. In 2013, she was awarded a K23 Mentored Patient-Oriented Research Career Development Award via the NIH/ NIGMS for her project “Statin Therapy in Acute Influenza”. The study is a randomized controlled trial assessing the effect of atorvastatin on the host inflammatory response to influenza with both clinical and laboratory endpoints.
Topics for Talks by Maureen Chase
- Statins in Influenza
- Basics in Clinical Trial Design and Execution
About Katherine Berg
Dr. Katherine Berg is a Pulmonary and Critical Care physician at BIDMC and Assistant Professor of Medicine at Harvard Medical School. She is a graduate of the University of Massachusetts Medical School, and completed her Internal Medicine residency at Tufts Medical Center. She completed her fellowship in Pulmonary and Critical Care Medicine at the Harvard Combined Program. Dr. Berg’s clinical investigations focus on understanding how oxygen metabolism changes in the shock seen in severe sepsis and after cardiac arrest, and investigating the utility of metabolic resuscitation. She is currently Principal Investigator of the randomized trial of thiamine to improve oxygen consumption after in-hospital cardiac arrest (THICA) and a co-investigator of the trial of thiamine as a metabolic resuscitator after out-of-hospital cardiac arrest (THACA) trial, as well as multiple other CRS studies. She has recently expanded her clinical and research interests to interventions to maximize long-term recovery after cardiac arrest and other critical illness. She is part of the core faculty of the Critical Illness Survivorship Program, where she sees patients weekly. Dr. Berg is the Chair of the Advanced Life Support Task Force at the International Liaison Committee on Resuscitation, and Chair of the writing group for the 2025 American Heart Association Post-cardiac Arrest Care Guidelines.
Topics for Talks by Katherine Berg
- In-hospital cardiac arrest (management, guidelines, controversies)
- Oxygen consumption in the critically ill
- Metabolic resuscitation in sepsis and cardiac arrest
About Ari Moskowitz
Dr. Ari Moskowitz is a Pulmonary and Critical Care attending at Beth Israel Deaconess Medical Center and an Instructor of Medicine in Harvard Medical School. Ari is originally from New York and completed medical school at the Mount Sinai (Icahn) School of Medicine. He trained in internal medicine at Beth Israel Deaconess Medical Center before starting his fellowship in the Harvard Combined Pulmonary and Critical fellowship program. Ari is interested in organ injury during sepsis and is currently funded by the National Institutes of Health to explore the role of thiamine in mitigating renal injury during septic shock.
Topics for Talks by Ari Moskowitz
- Metabolic resuscitation in septic shock
- In-hospital cardiac arrest prevention
- Post-arrest therapeutics and prognostication
- Nuts and bolts of clinical trials
- Misapplication of Severity of Illness Scores
About Anne Grossestreuer
Dr. Anne Grossestreuer is a Research Scientist in the Department of Emergency Medicine at Beth Israel Deaconess Medical Center, an Assistant Professor of Emergency Medicine at Harvard Medical School, and the Director of Epidemiology and Data Science at the Center for Resuscitation Science. She received her doctorate in Epidemiology from the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania. Dr. Grossestreuer’s research interests center on the definitive/supportive care that patients receive following successful resuscitation, outcomes after patients leave the hospital following critical illness, and the role of novel epidemiological methods in observation studies in critical care. She has served as Principal Investigator on awards from Harvard Catalyst and the American Heart Association. She serves as lead statistician for many of the CRS trials and provides statistical support for a variety of other studies within Emergency Medicine and Critical Care as well as the BIDMC Data Abstraction Core. Dr. Grossestreuer is a member of the Editorial Board of Resuscitation and the American Heart Association’s Get with the Guidelines – Resuscitation Adult Research Taskforce. Her research has won awards at the American Heart Association Resuscitation Science Symposium and the European Resuscitation Council Congress. She has additional research training in medical anthropology, in which she received an MSc from the University of Pennsylvania, and experience in health services research as a fellow at the Leonard Davis Institute of Healthcare Economics and health policy as a fellow at the Center for Emergency Care Policy Research.
Topics for Talks by Anne Grossestreuer
- Adaptive Clinical Trials
- Sensitivity and Specificity
- Introductory Biostatistics (short overview)
- Presentation of Data
- Types of Research Studies
- Power and Sample Size Calculations
- Immortal Time Bias
